Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- PROBIO ASA to acquire GELKAPS GmbH.
PROBIO has announced that it has entered into an agreement to acquire GELKAPS GmbH, one of Europe's leading manufacturers of pharmaceutical and nutraceutical grade soft gelatin capsules.
- PROBIO ASA to acquire GELKAPS GmbH.
PROBIO has announced that it has entered into an agreement to acquire GELKAPS GmbH, one of Europe's leading manufacturers of pharmaceutical and nutraceutical grade soft gelatin capsules.
- PROBIO ASA to acquire GELKAPS GmbH.
PROBIO has announced that it has entered into an agreement to acquire GELKAPS GmbH, one of Europe's leading manufacturers of pharmaceutical and nutraceutical grade soft gelatin capsules.
- PROBIO ASA to acquire GELKAPS GmbH.
PROBIO has announced that it has entered into an agreement to acquire GELKAPS GmbH, one of Europe's leading manufacturers of pharmaceutical and nutraceutical grade soft gelatin capsules.
- PROBIO ASA to acquire GELKAPS GmbH.
PROBIO has announced that it has entered into an agreement to acquire GELKAPS GmbH, one of Europe's leading manufacturers of pharmaceutical and nutraceutical grade soft gelatin capsules.
- Pharming signs Commercialization Agreement for Lactoferrin with Aslan Group A.S.
Pharming Group NV has announced that has signed a commercialization and supply agreement with Aslan Group A.S. in Turkey for the marketing and distribution of food or food supplements containing Pharming's human lactoferrin product (hLF).
- Pharming signs Commercialization Agreement for Lactoferrin with Aslan Group A.S.
Pharming Group NV has announced that has signed a commercialization and supply agreement with Aslan Group A.S. in Turkey for the marketing and distribution of food or food supplements containing Pharming's human lactoferrin product (hLF).
- Pharming signs Commercialization Agreement for Lactoferrin with Aslan Group A.S.
Pharming Group NV has announced that has signed a commercialization and supply agreement with Aslan Group A.S. in Turkey for the marketing and distribution of food or food supplements containing Pharming's human lactoferrin product (hLF).
- Pharming signs Commercialization Agreement for Lactoferrin with Aslan Group A.S.
Pharming Group NV has announced that has signed a commercialization and supply agreement with Aslan Group A.S. in Turkey for the marketing and distribution of food or food supplements containing Pharming's human lactoferrin product (hLF).
- Danisco A/S announces sale of Danisco Sugar A/S to Nordzucker AG
Danisco A/S has announced that it has agreed to sell Danisco Sugar A/S to Nordzucker AG for an enterprise value of DKK 5,600 million. In addition, Danisco will receive DKK 600 million of cash proceeds from the sale of EU quota in 2007/08 and earlier
- Danisco A/S announces sale of Danisco Sugar A/S to Nordzucker AG
Danisco A/S has announced that it has agreed to sell Danisco Sugar A/S to Nordzucker AG for an enterprise value of DKK 5,600 million. In addition, Danisco will receive DKK 600 million of cash proceeds from the sale of EU quota in 2007/08 and earlier
- Danisco A/S announces sale of Danisco Sugar A/S to Nordzucker AG
Danisco A/S has announced that it has agreed to sell Danisco Sugar A/S to Nordzucker AG for an enterprise value of DKK 5,600 million. In addition, Danisco will receive DKK 600 million of cash proceeds from the sale of EU quota in 2007/08 and earlier
- Danisco A/S announces sale of Danisco Sugar A/S to Nordzucker AG
Danisco A/S has announced that it has agreed to sell Danisco Sugar A/S to Nordzucker AG for an enterprise value of DKK 5,600 million. In addition, Danisco will receive DKK 600 million of cash proceeds from the sale of EU quota in 2007/08 and earlier
- BI Nutraceuticals' Pontiakos to Discuss the North American Organic Ingredient Market at Natural Products Conference in Athens, Greece
BI Nutraceuticals has announced that its president and CEO, George Pontiakos, has been invited to present, "Organic and Herbal Ingredient Trends in North America," at the 7th Joint Meeting of AFERP, ASP, GA, PSE & SIF, running August 3 - 8 at the Athenaeum Intercontinental Hotel in Athens, Greece.
- BI Nutraceuticals' Pontiakos to Discuss the North American Organic Ingredient Market at Natural Products Conference in Athens, Greece
BI Nutraceuticals has announced that its president and CEO, George Pontiakos, has been invited to present, "Organic and Herbal Ingredient Trends in North America," at the 7th Joint Meeting of AFERP, ASP, GA, PSE & SIF, running August 3 - 8 at the Athenaeum Intercontinental Hotel in Athens, Greece.
- BI Nutraceuticals' Pontiakos to Discuss the North American Organic Ingredient Market at Natural Products Conference in Athens, Greece
BI Nutraceuticals has announced that its president and CEO, George Pontiakos, has been invited to present, "Organic and Herbal Ingredient Trends in North America," at the 7th Joint Meeting of AFERP, ASP, GA, PSE & SIF, running August 3 - 8 at the Athenaeum Intercontinental Hotel in Athens, Greece.
- BI Nutraceuticals' Pontiakos to Discuss the North American Organic Ingredient Market at Natural Products Conference in Athens, Greece
BI Nutraceuticals has announced that its president and CEO, George Pontiakos, has been invited to present, "Organic and Herbal Ingredient Trends in North America," at the 7th Joint Meeting of AFERP, ASP, GA, PSE & SIF, running August 3 - 8 at the Athenaeum Intercontinental Hotel in Athens, Greece.
- BI Nutraceuticals' Pontiakos to Discuss the North American Organic Ingredient Market at Natural Products Conference in Athens, Greece
BI Nutraceuticals has announced that its president and CEO, George Pontiakos, has been invited to present, "Organic and Herbal Ingredient Trends in North America," at the 7th Joint Meeting of AFERP, ASP, GA, PSE & SIF, running August 3 - 8 at the Athenaeum Intercontinental Hotel in Athens, Greece.
- BI Nutraceuticals' Pontiakos to Discuss the North American Organic Ingredient Market at Natural Products Conference in Athens, Greece
BI Nutraceuticals has announced that its president and CEO, George Pontiakos, has been invited to present, "Organic and Herbal Ingredient Trends in North America," at the 7th Joint Meeting of AFERP, ASP, GA, PSE & SIF, running August 3 - 8 at the Athenaeum Intercontinental Hotel in Athens, Greece.
- Marketing to the YouTube Generation at the Healthy Foods European Summit
The second day of the forthcoming 2008 Healthy Foods European Summit sees a major session on new marketing and branding opportunities. The session will give insights into how to market to future generations and what strategies manufacturers and ingredient suppliers should be looking at to address the latest consumer demamands.
- Marketing to the YouTube Generation at the Healthy Foods European Summit
The second day of the forthcoming 2008 Healthy Foods European Summit sees a major session on new marketing and branding opportunities. The session will give insights into how to market to future generations and what strategies manufacturers and ingredient suppliers should be looking at to address the latest consumer demamands.
- Marketing to the YouTube Generation at the Healthy Foods European Summit
The second day of the forthcoming 2008 Healthy Foods European Summit sees a major session on new marketing and branding opportunities. The session will give insights into how to market to future generations and what strategies manufacturers and ingredient suppliers should be looking at to address the latest consumer demamands.
- Marketing to the YouTube Generation at the Healthy Foods European Summit
The second day of the forthcoming 2008 Healthy Foods European Summit sees a major session on new marketing and branding opportunities. The session will give insights into how to market to future generations and what strategies manufacturers and ingredient suppliers should be looking at to address the latest consumer demamands.
- Marketing to the YouTube Generation at the Healthy Foods European Summit
The second day of the forthcoming 2008 Healthy Foods European Summit sees a major session on new marketing and branding opportunities. The session will give insights into how to market to future generations and what strategies manufacturers and ingredient suppliers should be looking at to address the latest consumer demamands.
- Marketing to the YouTube Generation at the Healthy Foods European Summit
The second day of the forthcoming 2008 Healthy Foods European Summit sees a major session on new marketing and branding opportunities. The session will give insights into how to market to future generations and what strategies manufacturers and ingredient suppliers should be looking at to address the latest consumer demamands.
- Marketing to the YouTube Generation at the Healthy Foods European Summit
The second day of the forthcoming 2008 Healthy Foods European Summit sees a major session on new marketing and branding opportunities. The session will give insights into how to market to future generations and what strategies manufacturers and ingredient suppliers should be looking at to address the latest consumer demamands.
- Marketing to the YouTube Generation at the Healthy Foods European Summit
The second day of the forthcoming 2008 Healthy Foods European Summit sees a major session on new marketing and branding opportunities. The session will give insights into how to market to future generations and what strategies manufacturers and ingredient suppliers should be looking at to address the latest consumer demamands.
- Market Leader Beneo-Orafti Set to Reveal New Consumer Findings At Health Ingredients Europe
BENEO- Orafti will be exhibiting under the BENEO-Group banner at this year's Health Ingredients Europe (HIE) show in France, unveiling findings from its in-depth global consumer research program designed to udnerstand what resonates with today's evolving consumer consciousness within the arena of health and wellness.
- Market Leader Beneo-Orafti Set to Reveal New Consumer Findings At Health Ingredients Europe
BENEO- Orafti will be exhibiting under the BENEO-Group banner at this year's Health Ingredients Europe (HIE) show in France, unveiling findings from its in-depth global consumer research program designed to udnerstand what resonates with today's evolving consumer consciousness within the arena of health and wellness.
- Market Leader Beneo-Orafti Set to Reveal New Consumer Findings At Health Ingredients Europe
BENEO- Orafti will be exhibiting under the BENEO-Group banner at this year's Health Ingredients Europe (HIE) show in France, unveiling findings from its in-depth global consumer research program designed to udnerstand what resonates with today's evolving consumer consciousness within the arena of health and wellness.
- Market Leader Beneo-Orafti Set to Reveal New Consumer Findings At Health Ingredients Europe
BENEO- Orafti will be exhibiting under the BENEO-Group banner at this year's Health Ingredients Europe (HIE) show in France, unveiling findings from its in-depth global consumer research program designed to udnerstand what resonates with today's evolving consumer consciousness within the arena of health and wellness.
- BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 )
BioGaia has announced their interim report for January 1, 2008 through June 30, 2008, reporting (previous year's results are in brackets)net sales amounted to SEK 72.4 million (51.2), an increase of 41% compared to the same period of last year. Gross profit reached SEK 47.8 million, an improvement of SEK 13.6 million over the same period of last year. Profit after tax was SEK 22.1 million (3.3), an increase of SEK 18.8 million compared to the same period of last year.
- BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 )
BioGaia has announced their interim report for January 1, 2008 through June 30, 2008, reporting (previous year's results are in brackets)net sales amounted to SEK 72.4 million (51.2), an increase of 41% compared to the same period of last year. Gross profit reached SEK 47.8 million, an improvement of SEK 13.6 million over the same period of last year. Profit after tax was SEK 22.1 million (3.3), an increase of SEK 18.8 million compared to the same period of last year.
- BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 )
BioGaia has announced their interim report for January 1, 2008 through June 30, 2008, reporting (previous year's results are in brackets)net sales amounted to SEK 72.4 million (51.2), an increase of 41% compared to the same period of last year. Gross profit reached SEK 47.8 million, an improvement of SEK 13.6 million over the same period of last year. Profit after tax was SEK 22.1 million (3.3), an increase of SEK 18.8 million compared to the same period of last year.
- BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 )
BioGaia has announced their interim report for January 1, 2008 through June 30, 2008, reporting (previous year's results are in brackets)net sales amounted to SEK 72.4 million (51.2), an increase of 41% compared to the same period of last year. Gross profit reached SEK 47.8 million, an improvement of SEK 13.6 million over the same period of last year. Profit after tax was SEK 22.1 million (3.3), an increase of SEK 18.8 million compared to the same period of last year.
- BioGaia Enters Agreement With Nestlé Nutrition
BioGaia AB has signed an agreement with Nestlé Nutrition, giving Nestlé rights to use Lactobacillus reuteri in infant formula in a large number of countries.
- BioGaia Enters Agreement With Nestlé Nutrition
BioGaia AB has signed an agreement with Nestlé Nutrition, giving Nestlé rights to use Lactobacillus reuteri in infant formula in a large number of countries.
- BioGaia Enters Agreement With Nestlé Nutrition
BioGaia AB has signed an agreement with Nestlé Nutrition, giving Nestlé rights to use Lactobacillus reuteri in infant formula in a large number of countries.
- BioGaia Enters Agreement With Nestlé Nutrition
BioGaia AB has signed an agreement with Nestlé Nutrition, giving Nestlé rights to use Lactobacillus reuteri in infant formula in a large number of countries.
- BioGaia Enters Agreement With Nestlé Nutrition
BioGaia AB has signed an agreement with Nestlé Nutrition, giving Nestlé rights to use Lactobacillus reuteri in infant formula in a large number of countries.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EU as a global exporter of regulation
Simon Pettman, Director of international food and nutrition policy consultancy EAS, said that EU efforts to harmonise regulations across its 27 member states has drawn interest across the globe, highlighting that in many areas including the food sector, Europe is fast becoming an exporter of regulation.
- EU as a global exporter of regulation
Simon Pettman, Director of international food and nutrition policy consultancy EAS, said that EU efforts to harmonise regulations across its 27 member states has drawn interest across the globe, highlighting that in many areas including the food sector, Europe is fast becoming an exporter of regulation.
- EU as a global exporter of regulation
Simon Pettman, Director of international food and nutrition policy consultancy EAS, said that EU efforts to harmonise regulations across its 27 member states has drawn interest across the globe, highlighting that in many areas including the food sector, Europe is fast becoming an exporter of regulation.
- EU as a global exporter of regulation
Simon Pettman, Director of international food and nutrition policy consultancy EAS, said that EU efforts to harmonise regulations across its 27 member states has drawn interest across the globe, highlighting that in many areas including the food sector, Europe is fast becoming an exporter of regulation.
- EU as a global exporter of regulation
Simon Pettman, Director of international food and nutrition policy consultancy EAS, said that EU efforts to harmonise regulations across its 27 member states has drawn interest across the globe, highlighting that in many areas including the food sector, Europe is fast becoming an exporter of regulation.
- EU as a global exporter of regulation
Simon Pettman, Director of international food and nutrition policy consultancy EAS, said that EU efforts to harmonise regulations across its 27 member states has drawn interest across the globe, highlighting that in many areas including the food sector, Europe is fast becoming an exporter of regulation.
- EU as a global exporter of regulation
Simon Pettman, Director of international food and nutrition policy consultancy EAS, said that EU efforts to harmonise regulations across its 27 member states has drawn interest across the globe, highlighting that in many areas including the food sector, Europe is fast becoming an exporter of regulation.
- Scientific Event Puts Spotlight on the Role of Nutrition in Women's Health, Early Childhood and Adolescence
Scientists will focus on the role of food supplements in women’s health, early childhood and adolescence at an upcoming scientific conference in London organised by the UK Council for Responsible Nutrition (CRN). The event will take place on 28 April 2009 at the Royal College of Physicians in London.
- Scientific Event Puts Spotlight on the Role of Nutrition in Women's Health, Early Childhood and Adolescence
Scientists will focus on the role of food supplements in women’s health, early childhood and adolescence at an upcoming scientific conference in London organised by the UK Council for Responsible Nutrition (CRN). The event will take place on 28 April 2009 at the Royal College of Physicians in London.
- Scientific Event Puts Spotlight on the Role of Nutrition in Women's Health, Early Childhood and Adolescence
Scientists will focus on the role of food supplements in women’s health, early childhood and adolescence at an upcoming scientific conference in London organised by the UK Council for Responsible Nutrition (CRN). The event will take place on 28 April 2009 at the Royal College of Physicians in London.
- Scientific Event Puts Spotlight on the Role of Nutrition in Women's Health, Early Childhood and Adolescence
Scientists will focus on the role of food supplements in women’s health, early childhood and adolescence at an upcoming scientific conference in London organised by the UK Council for Responsible Nutrition (CRN). The event will take place on 28 April 2009 at the Royal College of Physicians in London.
- Scientific Event Puts Spotlight on the Role of Nutrition in Women's Health, Early Childhood and Adolescence
Scientists will focus on the role of food supplements in women’s health, early childhood and adolescence at an upcoming scientific conference in London organised by the UK Council for Responsible Nutrition (CRN). The event will take place on 28 April 2009 at the Royal College of Physicians in London.
- Scientific Event Puts Spotlight on the Role of Nutrition in Women's Health, Early Childhood and Adolescence
Scientists will focus on the role of food supplements in women’s health, early childhood and adolescence at an upcoming scientific conference in London organised by the UK Council for Responsible Nutrition (CRN). The event will take place on 28 April 2009 at the Royal College of Physicians in London.
- Scientific Event Puts Spotlight on the Role of Nutrition in Women's Health, Early Childhood and Adolescence
Scientists will focus on the role of food supplements in women’s health, early childhood and adolescence at an upcoming scientific conference in London organised by the UK Council for Responsible Nutrition (CRN). The event will take place on 28 April 2009 at the Royal College of Physicians in London.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Forbes Medi-Tech Inc. announced the introduction of an innovative processed cheese slice containing the Company's proprietary cholesterol-lowering ingredient, Reducol(tm). Available through the Pirkka Reducol(TM) product range -- jointly developed by Kesko Food and Scanvit Ltd -- the processed cheese slices will initially be available in Finland.
With Reducol(TM) already incorporated into a variety of foods -- including yoghurts, yoghurt drinks, breads, milk drinks and spreads -- European consumers will now be able to include Reducol(TM) cheese slices in meals and snacks, such as grilled cheese and deli sandwiches. Rupp AG, an Austrian-based cheese company with over 100 years' experience in the food industry, will produce the cheese slices containing Reducol(tm).
"Drawing upon our vast knowledge of food science and manufacturing processes, we are constantly striving to meet evolving consumer demands and further broaden the range of foods containing Reducol(tm). This processed cheese product containing our cholesterol-lowering ingredient, Reducol(tm), will give consumers even more dietary choices to lower their cholesterol," said Laura Wessman, Senior Vice President, Operations.
About Reducol
Reducol(TM) is a unique ingredient containing plant sterols and stanols, commonly known as phytosterols, which have been clinically proven to significantly lower Low Density Lipoprotein (LDL) or "bad" cholesterol. The ingredient does not change the sensory properties of foods, and can be formulated alone, or in combination with other active ingredients, for dietary supplements. Additional information on Reducol(TM) may be found at:
www.reducol.com
About Forbes Medi-Tech
Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its
Reducol(TM) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower "LDL" cholesterol levels safely and naturally. Building upon established partnerships with leading retailers and manufacturers across the globe, Forbes helps its customers to develop private label and branded products. For more information about Forbes Medi-Tech, please visit www.forbesmedi.com.
This News Release contains forward-looking statements and forward-looking information, within the meaning of applicable securities laws (collectively, "forward-looking statements"), regarding the launch of a process cheese slice containing Reducol(tm), and Forbes' goals. Forward-looking statements can be identified by forward-looking terminology such as "will", "to meet", "further broaden", and similar expressions or variations thereon.
Forward-looking statements are inherently uncertain, and actual results may differ materially from the forward-looking statements due to a variety of risks, uncertainties and other factors, including, without limitation, uncertainty whether the process cheese slices will obtain market acceptance; reliance by the Company on orders for Reducol(TM) by Rupp AG, Kesko Food and Scanvit Ltd.; uncertainty as to sales volumes and revenue; the Company's need for additional future capital, which is not assured; the Company's dependence on a few, and its need for additional, customers; risks inherent in new product development; competition; intellectual property, product liability and insurance risks; manufacturing risks and the Company's dependency on a single manufacturer for its supplies of Reducol(tm); exchange rate fluctuations; and changes in the Company's business strategy or plans. For a further discussion of these and other known risks and uncertainties affecting the Company and its business, please see our latest Annual Information Form / Form 20-F, and other documents filed by us with Canadian and U.S. securities regulatory authorities at www.sedar.com and www.sec.gov. Forward-looking statements are based on the beliefs, assumptions, and expectations of the Company's management at the time they are made, and the Company does not assume any obligation, except as required by law, to update its forward-looking statements if those beliefs, assumptions, or expectations or other circumstances should change.
Reducol(TM) is a trademark of Forbes Medi-Tech Inc. |